OTC · Medical - Devices

Olympus Corporation (OCPNF) Stock

$11.00 +0.00% OTC: OCPNF Healthcare

Established in Tokyo, Japan, in 1919, Olympus Corporation is a global leader in the manufacturing and distribution of advanced precision machinery and scientific instruments. The company structures its diverse operations into four main segments.

Valuation

MetricValue
Price$11.00
Market Cap$12.11B
P/E Ratio27.90
P/B Ratio2.33
P/S Ratio1.87
EPS (TTM)$0.39
52-Week High$14.00
52-Week Low$8.00
Dividend Yield3.36%

Financials & Margins

MetricValue
ROE8.94%
ROA4.43%
ROCE13.36%
Gross Margin64.72%
Operating Margin14.55%
Net Margin6.75%
Debt/Equity0.30
Current Ratio1.62

Annual Financials (USD)

Metric20222023202420252026
Revenue$868.9B$881.9B$936.2B$997.3B$1.02T
Operating Profit$166.3B$186.6B$151.9B$162.5B$147.9B
Net Profit$115.7B$143.4B$242.6B$117.9B$68.6B
EPS$90.17$108.65$21.88$102.80$62.31
Op Margin19.1%21.2%16.2%16.3%14.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$1.36T$1.51T$1.53T$1.43T$1.55T
Total Liabilities$844.6B$865.3B$777.0B$681.1B$729.7B
Cash$294.6B$164.6B$340.9B$252.5B$189.2B
Borrowings$386.1B$340.1B$299.6B$229.1B$241.1B

Latest News

Olympus Reports First Quarter Fiscal 2027 Financial Results PR Newswire · Aug 7, 2026 [Latest] Global AI In Digital Pathology Market Size/Share Worth USD 5.14 Billion by 2035 at a 18.02% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire · Aug 5, 2026 Olympus Announces Federal Healthcare Facility Distribution Agreement with First Nation Group PR Newswire · Jun 24, 2026 [Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) GlobeNewswire · Jun 10, 2026 Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer PR Newswire · May 26, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$169.7B$98.5B$42.4B$190.5B$101.2B
Investing Cash Flow$-132.8B$-129.0B$295.4B$-130.7B$-143.9B
Financing Cash Flow$-49.7B$-71.8B$-205.9B$-120.5B$-70.4B
Net Cash Flow$85.1B$-97.1B$135.4B$-88.4B$62.2B
Free Cash Flow$108.0B$27.9B$-22.3B$125.3B$45.3B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.69
EV / EBITDA11.36
FCF Yield2.39%
Quick Ratio1.14
Interest Coverage15.81
Return 1Y-3.93%
Return 3Y-29.57%
Return 5Y-47.35%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALBBYAlibaba Health Information Technology Limited $8.60 -7.63% 24.56 $6.93B 0.00%
ALBHFAlibaba Health Information Technology Limited $0.45 +9.93% 24.85 $7.34B 24.44%
BMXMFbioMérieux S.A. $80.31 +0.00% 20.73 $9.48B 1.41%
CHJTFCSPC Pharmaceutical Group Limited $0.98 +0.00% 21.72 $11.18B 4.08%
ERFSFEurofins Scientific SE $81.74 +5.24% 27.93 $14.14B 1.03%

About Olympus Corporation

Established in Tokyo, Japan, in 1919, Olympus Corporation is a global leader in the manufacturing and distribution of advanced precision machinery and scientific instruments. The company structures its diverse operations into four main segments. Its Endoscopic Solutions division provides sophisticated endoscopic tools for gastrointestinal and surgical procedures, along with complete endoscopy systems and crucial repair services. The Therapeutic Solutions segment delivers specialized medical devices for urology, gynecology, and otolaryngology (ear, nose, and throat), alongside endo-therapy and energy-based devices, and single-use surgical instruments. Under its Scientific Solutions umbrella, Olympus supplies an array of biological and industrial microscopes, industrial inspection equipment including endoscopes and videoscopes, non-destructive testing apparatus, and X-ray fluorescence (XRF) analyzers. The "Others" category encompasses biomedical materials and orthopedic equipment. Furthermore, Olympus's extensive offerings include additional medical technologies such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, supported by system integration and comprehensive maintenance and service programs. The company, which was originally known as Olympus Optical Co., Ltd., officially rebranded as Olympus Corporation in October 2003.

Olympus Corporation is headquartered in JP.

Olympus Corporation (OCPNF) stock trades at $11.00 with a market capitalization of $12.11B. The stock is valued at a price-to-earnings (P/E) ratio of 27.90, price-to-book of 2.33, price-to-sales of 1.87. Over the past 52 weeks the stock has ranged between $8.00 and $14.00, and currently trades 21.4% below its 52-week high. It pays a dividend yielding 3.36%.

On profitability, Olympus Corporation generates a return on equity (ROE) of 8.94%, return on capital employed of 13.36%, an operating margin of 14.55%, a net profit margin of 6.75%.

Official website: www.olympus.co.jp

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides